Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis

Background. The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is unclear. Methods. We conducted a systematic review and meta-analysis of randomized controlled trials evaluating risk of adverse events in participants receiving different durations...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwok, Chun Shing, Bulluck, Heerajnarain, Ryding, Alisdair D., Loke, Yoon K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958680/
https://www.ncbi.nlm.nih.gov/pubmed/24723825
http://dx.doi.org/10.1155/2014/794078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958680/
https://www.ncbi.nlm.nih.gov/pubmed/24723825
http://dx.doi.org/10.1155/2014/794078

Ejemplares similares